Tsopanoglou N E, Pipili-Synetos E, Maragoudakis M E
Department of Pharmacology, Medical School, University of Patras, Greece.
J Vasc Res. 1993 Jul-Aug;30(4):202-8. doi: 10.1159/000158995.
Using the chick chorioallantoic membrane as a model system for the study of angiogenesis, we have shown that promoters of protein kinase C (PKC) such as 4-beta-phorbol-12-myristate-13-acetate (4-beta-PMA) and 1,2-dioctanoyl-sn-glycerol (DiC8) stimulated angiogenesis. This effect was specific since 4-alpha-PMA and 1,2-dioleoyl-sn-glycerol, which either do not activate or cannot reach PKC, were devoid of angiogenic activity. Furthermore, Ro 31-8220, a specific inhibitor of PKC, suppressed both basal and 4-beta-PMA- or DiC8-induced angiogenesis. Similar results were obtained with the commonly used inhibitor of PKC, 1-(5-isoquinoline-sulfonyl)-2-methylpiperazine and with tricyclodecan-9-yl-xanthogenate, an antitumor agent which has been suggested to be an inhibitor of PKC. Activation of PKC may be, therefore, an important signalling pathway in the initiation and control of the angiogenic response.
以鸡胚绒毛尿囊膜作为研究血管生成的模型系统,我们发现蛋白激酶C(PKC)的激活剂,如4-β-佛波醇-12-肉豆蔻酸酯-13-乙酸酯(4-β-PMA)和1,2-二辛酰-sn-甘油(DiC8),可刺激血管生成。这种效应具有特异性,因为4-α-PMA和1,2-二油酰-sn-甘油既不激活PKC也无法作用于PKC,它们没有血管生成活性。此外,PKC的特异性抑制剂Ro 31-8220可抑制基础状态下以及4-β-PMA或DiC8诱导的血管生成。使用常用的PKC抑制剂1-(5-异喹啉磺酰基)-2-甲基哌嗪以及已被认为是PKC抑制剂的抗肿瘤药物三环癸烷-9-基-黄原酸酯也得到了类似结果。因此,PKC的激活可能是血管生成反应起始和调控过程中的一条重要信号通路。